World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
20747
World Ranking
2725
National Ranking
107

Piero Musiani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Piero Musiani sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 224 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Piero Musiani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Piero Musiani sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Piero Musiani was affiliated with the University of Chieti-Pescara in Italy. Their research focused primarily on fields related to Agricultural and Biological Sciences as well as Biochemistry, Genetics, and Molecular Biology. Within these broader fields, their work specifically encompassed subfields such as Food Science, Cancer Research, and Plant Science.

The main topics covered in Musiani's research included Potato Plant Research, Carcinogens and Genotoxicity Assessment, and Plant Pathogens and Resistance. These areas reflect an interdisciplinary approach linking plant biology and molecular assessments of carcinogenic agents.

Musiani contributed to scholarly publications, with at least one recent paper recorded. This paper, published in 2021, was titled Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan. It appeared in the International Journal of Molecular Sciences.

  • Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan (2021, International Journal of Molecular Sciences)

Frequent co-authors in Musiani's work included Maria Teresa Russo, Gabriele De Luca, Nieves Palma, P. Leopardi, and Paolo Degan, indicating collaborative research involving multiple experts in related fields.

  • Maria Teresa Russo
  • Gabriele De Luca
  • Nieves Palma
  • P. Leopardi
  • Paolo Degan

The publication venues where Musiani's work appeared also centered around the International Journal of Molecular Sciences, which hosted at least one of their known scholarly articles.

  • International Journal of Molecular Sciences

Best Publications

  • Systemic spread is an early step in breast cancer.

    Yves Hüsemann;Jochen B. Geigl;Falk Schubert;Piero Musiani

  • The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

    Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

  • Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice.

    I Screpanti;L Romani;P Musiani;A Modesti

  • DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

    Stefania Rovero;Augusto Amici;Emma Di Carlo;Roberto Bei

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

    Carmela De Santo;Paolo Serafini;Ilaria Marigo;Luigi Dolcetti

  • Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development

    Elisa Ciraolo;Manuela Iezzi;Romina Marone;Stefano Marengo

  • Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

    Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  • Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

    M Giovarelli;P Musiani;A Modesti;P Dellabona

  • CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

    Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

  • IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage

    Elena Fattori;Domenico Lazzaro;Piero Musiani;Andrea Modesti

  • Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

    Federica Cavallo;Paola Signorelli;Mirella Giovarelli;Piero Musiani

  • IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice

    Emma Di Carlo;Alberto Comes;Anna Maria Orengo;Ombretta Rosso

  • Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

    Elena Quaglino;Manuela Iezzi;Cristina Mastini;Augusto Amici

  • IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.

    M Ferrantini;M Giovarelli;A Modesti;P Musiani

  • Immune Events Associated with the Cure of Established Tumors and Spontaneous Metastases by Local and Systemic Interleukin 12

    Federica Cavallo;Emma Di Carlo;Monia Butera;Roberta Verrua

  • Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice

    Giuseppe Lattanzio;Claude Libert;Massimo Aquilina;Manuela Cappelletti

  • Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver

    Domenico Maione;Emma Di Carlo;Wei Li;Piero Musiani

  • Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes

    Mauro Brunetti;Nicola Martelli;Antonella Colasante;Mauro Piantelli

  • Immunoprevention of Cancer: Is the Time Ripe?

    Guido Forni;Pier Luigi Lollini;Piero Musiani;Mario P. Colombo

Frequent Co-Authors

Guido Forni
Guido Forni University of Turin
Emma Di Carlo
Emma Di Carlo University of Chieti-Pescara
Federica Cavallo
Federica Cavallo University of Turin
Patrizia Nanni
Patrizia Nanni University of Bologna
Andrea Modesti
Andrea Modesti University of Rome Tor Vergata
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Mirella Giovarelli
Mirella Giovarelli University of Turin
Silvano Ferrini
Silvano Ferrini University of Genoa
Luigi Maria Larocca
Luigi Maria Larocca Catholic University of the Sacred Heart
Raffaele A. Calogero
Raffaele A. Calogero University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare careers, many of which can be pursued through online education. For those interested in nursing but without a healthcare background, there are excellent options like online nursing programs for non nurses. These programs provide foundational knowledge and hands-on skills needed to enter the nursing field efficiently.

If you’re aiming for a faster track, exploring the easiest accelerated nursing programs to get into could be a great fit. They cater to individuals who want to transition quickly into nursing roles with a Bachelor of Science in Nursing (BSN).

For those beginning with practical nursing, which lpn programs are easiest to get into is a useful resource. Licensed Practical Nurse programs offer quicker entry into patient care, making it a practical step while considering further specialization in immunology-related healthcare.

Advancing further, becoming a nurse practitioner with a specialty in immunology or related fields is possible through which nurse practitioner program is easiest programs. These pathways allow for developing advanced clinical skills and greater career flexibility in immunology and beyond.

Best Scientists Citing Piero Musiani

Recently Published Articles